🚀 VC round data is live in beta, check it out!
Blue Jet Healthcare Valuation Multiples
Discover revenue and EBITDA valuation multiples for Blue Jet Healthcare and similar public comparables like Lexicon Pharmaceuticals, Allogene Therapeutics, Relmada Therapeutics, Chong Kun Dang Pharma and more.
Blue Jet Healthcare Overview
About Blue Jet Healthcare
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
Founded
1968
HQ
Employees
491
Website
Sectors
Financials (LTM)
EV
$749M
Blue Jet Healthcare Financials
Blue Jet Healthcare reported last 12-month revenue of $108M and EBITDA of $34M.
In the same LTM period, Blue Jet Healthcare generated $60M in gross profit, $34M in EBITDA, and $28M in net income.
Revenue (LTM)
Blue Jet Healthcare P&L
In the most recent fiscal year, Blue Jet Healthcare reported revenue of $121M and EBITDA of $46M.
Blue Jet Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $108M | XXX | $121M | XXX | XXX | XXX |
| Gross Profit | $60M | XXX | $60M | XXX | XXX | XXX |
| Gross Margin | 56% | XXX | 50% | XXX | XXX | XXX |
| EBITDA | $34M | XXX | $46M | XXX | XXX | XXX |
| EBITDA Margin | 32% | XXX | 38% | XXX | XXX | XXX |
| EBIT Margin | 30% | XXX | 36% | XXX | XXX | XXX |
| Net Profit | $28M | XXX | $36M | XXX | XXX | XXX |
| Net Margin | 26% | XXX | 30% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Blue Jet Healthcare Stock Performance
Blue Jet Healthcare has current market cap of $792M, and enterprise value of $749M.
Market Cap Evolution
Blue Jet Healthcare's stock price is $4.57.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $749M | $792M | 0.5% | XXX | XXX | XXX | $0.21 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBlue Jet Healthcare Valuation Multiples
Blue Jet Healthcare trades at 7.0x EV/Revenue multiple, and 21.9x EV/EBITDA.
EV / Revenue (LTM)
Blue Jet Healthcare Financial Valuation Multiples
As of April 19, 2026, Blue Jet Healthcare has market cap of $792M and EV of $749M.
Equity research analysts estimate Blue Jet Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Blue Jet Healthcare has a P/E ratio of 28.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $792M | XXX | $792M | XXX | XXX | XXX |
| EV (current) | $749M | XXX | $749M | XXX | XXX | XXX |
| EV/Revenue | 7.0x | XXX | 6.2x | XXX | XXX | XXX |
| EV/EBITDA | 21.9x | XXX | 16.4x | XXX | XXX | XXX |
| EV/EBIT | 23.6x | XXX | 17.4x | XXX | XXX | XXX |
| EV/Gross Profit | 12.5x | XXX | 12.5x | XXX | XXX | XXX |
| P/E | 28.7x | XXX | 22.1x | XXX | XXX | XXX |
| EV/FCF | 163.7x | XXX | (234.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Blue Jet Healthcare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Blue Jet Healthcare Margins & Growth Rates
Blue Jet Healthcare's revenue in the last 12 month grew by 21%.
Blue Jet Healthcare's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Blue Jet Healthcare's rule of 40 is 48% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Blue Jet Healthcare's rule of X is 70% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Blue Jet Healthcare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 21% | XXX | (12%) | XXX | XXX | XXX |
| EBITDA Margin | 32% | XXX | 38% | XXX | XXX | XXX |
| EBITDA Growth | 27% | XXX | (27%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 48% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 70% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Blue Jet Healthcare Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Blue Jet Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Lexicon Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Allogene Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Relmada Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Chong Kun Dang Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Design Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Blue Jet Healthcare M&A Activity
Blue Jet Healthcare acquired XXX companies to date.
Last acquisition by Blue Jet Healthcare was on XXXXXXXX, XXXXX. Blue Jet Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Blue Jet Healthcare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBlue Jet Healthcare Investment Activity
Blue Jet Healthcare invested in XXX companies to date.
Blue Jet Healthcare made its latest investment on XXXXXXXX, XXXXX. Blue Jet Healthcare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Blue Jet Healthcare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Blue Jet Healthcare
| When was Blue Jet Healthcare founded? | Blue Jet Healthcare was founded in 1968. |
| Where is Blue Jet Healthcare headquartered? | Blue Jet Healthcare is headquartered in India. |
| How many employees does Blue Jet Healthcare have? | As of today, Blue Jet Healthcare has over 491 employees. |
| Is Blue Jet Healthcare publicly listed? | Yes, Blue Jet Healthcare is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Blue Jet Healthcare? | Blue Jet Healthcare trades under BLUEJET ticker. |
| When did Blue Jet Healthcare go public? | Blue Jet Healthcare went public in 2023. |
| Who are competitors of Blue Jet Healthcare? | Blue Jet Healthcare main competitors are Lexicon Pharmaceuticals, Allogene Therapeutics, Relmada Therapeutics, Chong Kun Dang Pharma. |
| What is the current market cap of Blue Jet Healthcare? | Blue Jet Healthcare's current market cap is $792M. |
| What is the current revenue of Blue Jet Healthcare? | Blue Jet Healthcare's last 12 months revenue is $108M. |
| What is the current revenue growth of Blue Jet Healthcare? | Blue Jet Healthcare revenue growth (NTM/LTM) is 21%. |
| What is the current EV/Revenue multiple of Blue Jet Healthcare? | Current revenue multiple of Blue Jet Healthcare is 7.0x. |
| Is Blue Jet Healthcare profitable? | Yes, Blue Jet Healthcare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Blue Jet Healthcare? | Blue Jet Healthcare's last 12 months EBITDA is $34M. |
| What is Blue Jet Healthcare's EBITDA margin? | Blue Jet Healthcare's last 12 months EBITDA margin is 32%. |
| What is the current EV/EBITDA multiple of Blue Jet Healthcare? | Current EBITDA multiple of Blue Jet Healthcare is 21.9x. |
| What is the current FCF of Blue Jet Healthcare? | Blue Jet Healthcare's last 12 months FCF is $5M. |
| What is Blue Jet Healthcare's FCF margin? | Blue Jet Healthcare's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Blue Jet Healthcare? | Current FCF multiple of Blue Jet Healthcare is 163.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.